A Patient Decision Aid About Conservative Kidney Management in Advanced Kidney Disease: A Randomized Pilot Trial

• DOI: 10.1053/j.ajkd.2022.12.007
• Publication Date: 2023-02-04T01:44:54Z
• Authors: Susan P.Y. Wong; Taryn Oestreich; David K. Prince; J. Randall Curtis
• Keywords: Attrition; Receipt

Available decision aids for patients about treatment of advanced chronic kidney disease (CKD) often lack information on conservative management (CKM). We assessed the feasibility and acceptability a aid CKM among with CKD their family members.Randomized pilot trial.Patients aged≥75 years stage 4 or 5 members at medical centers in greater Seattle area between August 2020 December 2021.Usual care without CKM.Acceptability was by attrition rates initial study visit (T1) 3-month follow-up evaluation (T3). The primary outcome measure proportion participants who discussed health provider T1 T3.We randomized 92 whom 86 (55.8% male; age 82±6 years; 82.6% White) completed T1-42 usual arm 44 plus arm-and 56 53 (18.9% 71±11 86.8% T1-20 33 decisions arm. were 21% versus (P=1.0) patients, 10% 18% (P=0.46) arms. Receipt significantly increased discussion (26.4% vs 3.0%, P=0.007) (26.9% 0, P=0.02).Possible limited generalizability because relatively homogenous group. focuses may be less applicable to those knowledge replacement therapies.A feasible acceptable, this option providers. This serve as useful adjunct currently available educational tools treatments CKD.Grant from not-for-profit entity (National Palliative Care Research Center).Registered ClinicalTrials.gov number NCT04919941.